Also known as: 1-hydroxycholecalciferol 1alpha-hydroxycholecalciferol 1alpha-hydroxyvitamin D3 Alphacalcidol
Alfacalcidol is indicated for:
Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 - 65 years old)
Alfacalcidol is indicated in all conditions where there is a disturbance of calcium metabolism due to impaired 1-α hydroxylation such as when there is reduced renal function.
The main indications are:
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: both men and women, only infants (40 days - 1 year old) , children (1 year - 12 years old)
Alfacalcidol is indicated in all conditions where there is a disturbance of calcium metabolism due to impaired 1-α hydroxylation such as when there is reduced renal function.
The main indications are:
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: both men and women, only elderly (65 years old or older)
Alfacalcidol is indicated in all conditions where there is a disturbance of calcium metabolism due to impaired 1-α hydroxylation such as when there is reduced renal function.
The main indications are:
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: both men and women, only newborns (0 - 40 days old)
Alfacalcidol is indicated in all conditions where there is a disturbance of calcium metabolism due to impaired 1-α hydroxylation such as when there is reduced renal function.
The main indications are:
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Alfacalcidol is contraindicated in the following cases: